Table 1 |
|||||||
|
Genetic studies for the identification of regulators of neurodegeneration models in C.elegans, S. cerevisiae and D. melanogaster |
|||||||
|
Study Number |
Primary model Organism |
Disease model |
Expressed construct |
Screen |
Number of Genetic modifiers |
Orthologues in C. elegans |
Reference |
|
|
|||||||
|
1 |
C. elegans |
P |
Htt-Q0, Q24, Q33, Q35, and Q40 |
Genome-wide RNAi |
186 |
186 |
[10] |
|
2 |
C. elegans |
SOD |
G85R SOD |
Genome-wide RNAi |
81 |
81 |
[11] |
|
3 |
C. elegans |
S |
WT α-synuclein |
Genome-wide RNAi |
82 |
82 |
[9] |
|
4 |
C. elegans |
T |
Tau P301L and V337M |
Genome-wide RNAi |
75 |
75 |
[14] |
|
5 |
C. elegans |
S |
WT α-synuclein |
Hypothesis-driven RNAi |
20 |
20 |
[65] |
|
6 |
C. elegans |
P |
Htt-Q150 |
Candidate genes |
12 |
12 |
[37] |
|
7 |
C. elegans |
S |
WT α-synuclein |
Systematic RNAi screen |
11 |
11 |
[68] |
|
8 |
C. elegans |
P |
Htt-Q128 |
Candidate genes |
4 |
4 |
[13] |
|
9 |
C. elegans |
Aβ |
Aβ1-42 |
Candidate genes |
2 |
2 |
[69] |
|
10 |
C. elegans |
T |
Tau P301L and V337M |
Forward genetic |
2 |
2 |
[70] |
|
11 |
C. elegans |
T |
Tau V337M |
Candidate genes |
2 |
2 |
[71] |
|
12 |
C. elegans |
P |
Htt-Q32, Q40, Q56, Q79 |
Candidate genes |
2 |
2 |
[72] |
|
13 |
C. elegans |
P |
Htt-Q2 and Q150 |
Candidate genes |
1 |
1 |
[12] |
|
14 |
S. cerevisiae |
P and S |
Htt-Q20, Htt-Q53, A53T α-synuclein |
Genome-wide genetic |
138 |
41 |
[24] |
|
15 |
S. cerevisiae |
S |
α-synuclein |
Selected genetic screen |
77 |
20 |
[73] |
|
16 |
S. cerevisiae |
Aβ |
Aβ1-42 |
Genome-wide genetic |
40 |
11 |
[60] |
|
17 |
S. cerevisiae |
P |
Htt-Q103 |
Genome-wide loss-of-function suppressor |
30 |
5 |
[50] |
|
18 |
S. cerevisiae |
S |
WT α-synuclein |
Genome-wide overexpression |
22 |
7 |
[58] |
|
19 |
S. cerevisiae |
S |
WT α-synuclein |
Candidate genes |
5 |
1 |
[59] |
|
20 |
D. melanogaster |
T |
Tau V337M |
Large-scale genetic |
30 |
14 |
[74] |
|
21 |
D. melanogaster |
P |
Htt-Q128 |
protein interaction and selected genetic screen |
32 |
34 |
[75] |
|
22 |
D. melanogaster |
P |
SCA182Q and Htt-Q128 |
Selective genetic modifier screen |
24 |
20 |
[34] |
|
23 |
D. melanogaster |
T |
Tau V337M |
Large-scale genetic |
24 |
10 |
[76] |
|
24 |
D. melanogaster |
P |
Htt-Q127 |
Selective genetic modifier screen |
10 |
2 |
[77] |
|
25 |
D. melanogaster |
P |
SCA3trQ78 |
Genome-wide screen |
18 |
17 |
[63] |
|
26 |
D. melanogaster |
P |
SCA1 30Q and 82Q |
Large-scale genetic |
17 |
11 |
[78] |
|
27 |
D. melanogaster |
P |
Htt-Q127 |
Genome-wide screen |
2 |
1 |
[79] |
|
28 |
D. melanogaster |
S |
A30P and A53T α-synuclein |
Candidate gene |
1 |
1 |
[80] |
|
Total |
950 |
675 |
|||||
|
|
|||||||
|
The number of regulators of neurodegeneration that were identified in each study is shown along with the number of these genes with orthologues in C elegans. The disease models include organisms expressing forms of β-amyloid (AB), polyQ expansions (P), wild type or mutant α-synuclein (S), mutant superoxide dismutase (SOD), or mutant tau (T). |
|||||||
|
Chen and Burgoyne BMC Genomics 2012 13:71 doi:10.1186/1471-2164-13-71 |
|||||||